ImaRx Therapeutics
1635 East 18th Street
Tucson
Arizona
85719-6803
United States
Tel: 520-770-1259
Fax: 520-791-2437
Website: http://www.imarx.com/netscape.htm
Email: imarx@imarx.com
45 articles about ImaRx Therapeutics
-
ImaRx Therapeutics to Re-Emerge as a Diversified Entertainment Company
6/18/2010
-
ImaRx Therapeutics Reports Second Quarter Ended 2009 Financial Results
8/11/2009
-
ImaRx Therapeutics Reports First Quarter Ended 2009 Financial Results
5/15/2009
-
ImaRx Therapeutics Reports Fourth Quarter and Year Ended 2008 Financial Results
3/9/2009
-
ImaRx Therapeutics Release: SonoLysis Clot Busting Ultrasound Therapy Demonstrates Promising Results for Treatment of Stroke Patients
2/19/2009
-
ImaRx Therapeutics Reports Third Quarter Ended 2008 Financial Results
11/13/2008
-
Delisting of Securities of ImaRx Therapeutics From The NASDAQ Stock Market
11/7/2008
-
ImaRx Therapeutics Receives NASDAQ Delisting Notification
10/17/2008
-
ImaRx Therapeutics Divests Urokinase Franchise to Microbix Biosystems Inc.
9/24/2008
-
ImaRx Therapeutics Reports Second Quarter Ended 2008 Financial Results
8/15/2008
-
Microbix Biosystems Inc. and ImaRx Therapeutics Agree to Terminate Letter of Intent to Acquire Urokinase Inventory and Related Assets from ImaRx for $17M
6/11/2008
-
ImaRx Therapeutics Reports First Quarter Ended 2008 Financial Results
5/16/2008
-
ImaRx Therapeutics Postpones Release of First Quarter 2008 Financial Results Live Webcast and Conference Call Scheduled for Thursday, May 15th at 5 PM ET
5/14/2008
-
ImaRx Therapeutics Schedules Release of First Quarter 2008 Financial Results
5/9/2008
-
ImaRx Therapeutics Satisfies Abbott Laboratories Note Obligation Associated With the Acquisition of Urokinase
4/25/2008
-
ImaRx Therapeutics Receives Notification from NASDAQ Regarding Non-Compliance
4/15/2008
-
ImaRx Therapeutics Reports Business Update and Financial Results for Fourth Quarter and Full Year 2007
4/1/2008
-
ImaRx Therapeutics Reschedules Release of Corporate Updates and Fourth Quarter and Full Year 2007 Financial Results
3/27/2008
-
ImaRx Therapeutics to Report Corporate Updates and 4Q07 Financial Results
3/21/2008
-
ImaRx Therapeutics to Explore Options for Ischemic Stroke Program
1/30/2008